ARHGEF38
protein-codingRho guanine nucleotide exchange factor 38, the group of Dbl family Rho GEFs|BAR and Dbl domain containing
Gene summary
Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Jul 2025]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~155.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0005258
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0016044
Submitter: PanelApp Australia
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ARHGEF38 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001242729.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | 2 | |||
| missense | 109 | 3 | 112 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 110 | 4 | 0 | 114 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001229658.1 | 14 | MANE Select | |
| Ensembl | ENSP00000416125.2 | 14 | MANE Select | |
| RefSeq | NP_060170.1 | 4 | Standard | |
| Ensembl | ENSP00000265154.2 | 4 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Signaling by GPCR
- Signal Transduction
- Rho GTPase cycle
- Signaling by Rho GTPases
- NRAGE signals death through JNK
Biological Process
- regulation of Rho protein signal transduction
Molecular Function
- Rho guanyl-nucleotide exchange factor activity
Cellular Component
- cytoplasm
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000420470
- Coding exons
- 14
- Length
- 155474
- Individuals with no LoFs
- 125264
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 469
- Defined
- 125735
- p
- 0.00187
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.649 | 338 | 373 | 0.906 | 0.0000186 | 5137 |
| Missense (PolyPhen) | 106 | 134.52 | 0.78798 | 1855 | ||
| Synonymous | 0.386 | 135 | 141 | 0.959 | 0.00000722 | 1398 |
| Loss of Function | 1.92 | 19 | 30.5 | 0.624 | 0.00000136 | 479 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.0024 | 0.0023 | notable |
| Ashkenazi Jewish | 0.024 | 0.023 | notable |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.0011 | 0.0011 | notable |
| South Asian | 0.00042 | 0.00039 | rare |
| Other | 0.0037 | 0.0036 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May act as a guanine-nucleotide releasing factor. {ECO:0000250}.;
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.114
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |